Germany· DE-A57-8f020de019fcae02
Ceftarolinfosamil Qilu
A ceftaroline fosamil product containing ceftaroline fosamil, registered in Germany by Qilu Pharma Spain S.L.. The same ATC class is registered in 13 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Ceftaroline fosamil is registered in 13 of 19 countries.
Countries holding a registration under ATC J01DI02 (ceftaroline fosamil), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 8 of them publish a price we can compare per daily dose
Ceftaroline fosamil · ATC J01DI02
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Ceftaroline Fosamil
- Manufacturer
- Qilu Pharma Spain S.L.
- Country
- Germany (DE)
- ATC code
- J01DI02
- ATC class
- Ceftaroline fosamil
- Defined daily dose
- 1.2 g, P
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- July 8, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
19 interactions on record for ceftaroline fosamil.
Graded by severity as the source publishes them — 19 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ceftaroline fosamil · interactions on record
19 records
- 19 moderate
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- NeomycinA07AA01moderate
- StreptomycinA07AA04moderate
- KanamycinA07AA08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ceftaroline fosamil in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCeftaroline FosamilApotex Corp.
- SpainCEFTAROLINA FOSAMILO QILU 600 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFGQilu Pharma Spain S.L.
- CzechiaZINFOROPfizer Ireland Pharmaceuticals, Ringaskiddy
- FinlandZinforoPfizer Ireland Pharmaceuticals Unlimited Company
- FranceZINFORO 600 mg, poudre pour solution à diluer pour perfusionPFIZER IRELAND PHARMACEUTICALS (IRLANDE)
- BelgiumZinforo 600 mgPfizer Ireland Pharmaceuticals Unlimited Company
- IrelandZinforo 600 mg powder for concentrate for solution for infusionPfizer Ireland Pharmaceuticals
- IcelandZinforoPfizer Ireland Pharmaceuticals
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Spain · Ceftarolina Fosamilo Qilu
- Iceland · Zinforo
- Italy · Ceftarolina Fosamil Qilu
- Liechtenstein · Zinforo
- Norway · Zinforo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8be0935c-5ef2-4674-985d-9dbb31326781 GET /v1/drugs/8be0935c-5ef2-4674-985d-9dbb31326781?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Ceftaroline Fosamil",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about ceftaroline fosamil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.